SVP and Site Head of Pfizer La Jolla to Give Plenary Keynote Address at 3rd Modern Drug Discovery & Development Summit
SVP and Site Head of Pfizer La Jolla announced as Plenary Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D).
San Francisco, CA, October 10, 2007 --(PR.com)-- Dr. Keith James, Senior Vice President and Site Head of Pfizer La Jolla is presenting at the Plenary Keynote session at GTCbio’s 3rd Modern Drug Discovery and Development Summit on November 28-30, 2007 at the Hyatt Regency San Francisco Airport.
Dr. James’ presentation will focus on building and maintaining a high performance research and development organization. He will discuss the operating model used at Pfizer which includes approaches such as keeping the focus on the patient, accountability for strategy and delivery, and the alignment of research, development and commercial dimensions to ensure success. Dr. James’ will also outline the importance of implementing clear performance expectations for organizations of any size.
The 3rd Modern Drug Discovery & Development Summit features over 150 speakers participating in 6 concurrent conferences, 6 study sessions and 3 pre-conference workshops. Tracks include Biological Therapeutics, Drug Delivery Technology, Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and Pharmaco – Kinetics, Dynamics, Genomics and Genetics. For more information, visit www.gtcbio.com.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Their goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
Dr. James’ presentation will focus on building and maintaining a high performance research and development organization. He will discuss the operating model used at Pfizer which includes approaches such as keeping the focus on the patient, accountability for strategy and delivery, and the alignment of research, development and commercial dimensions to ensure success. Dr. James’ will also outline the importance of implementing clear performance expectations for organizations of any size.
The 3rd Modern Drug Discovery & Development Summit features over 150 speakers participating in 6 concurrent conferences, 6 study sessions and 3 pre-conference workshops. Tracks include Biological Therapeutics, Drug Delivery Technology, Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and Pharmaco – Kinetics, Dynamics, Genomics and Genetics. For more information, visit www.gtcbio.com.
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Their goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com
###
Contact
GTCbio
Rania Hafez
626-256-6405
www.gtcbio.com
Rania Hafez
626-256-6405
www.gtcbio.com
Contact
Categories